# Risperidone vs Cariprazine in Acute Mania

> **NCT07665073** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Pakistan Institute of Medical Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Bipolar 1 Disorder

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Cariprazine

## Key facts

- **NCT ID:** NCT07665073
- **Lead sponsor:** Pakistan Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-06
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665073, "Risperidone vs Cariprazine in Acute Mania". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07665073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*